← Open Payments lookup

JESSICA GARCIA-OTERO: Open Payments

NPI 1811505811 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,615 in 126 payments from 14 companies in 2025. Trend: 2023 $856 · 2024 $984 · 2025 $2,615

Food & beverage: $2,615
CompanyPaymentsAmount
ABBVIE INC.30$602
Supernus Pharmaceuticals, Inc.24$446
E.R. Squibb & Sons, L.L.C.23$441
Alkermes, Inc.7$191
Otsuka America Pharmaceutical, Inc.7$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$127
Axsome Therapeutics, Inc.2$117
Vanda Pharmaceuticals Inc.5$99
Teva Pharmaceuticals USA, Inc.4$93
Corium, LLC5$89

Products named: VRAYLAR, Qelbree, COBENFY, ARISTADA, REXULTI, CAPLYTA, Auvelity, FANAPT.

Industry payments across IL — which companies pay providers there.